NCT07135466 2026-01-16
A Phase 1/2 Study of T-cell Expressing an Anti-CD22 Chimeric-Antigen Receptor (SHB-04-CD22) in Patients With CD22-expressing B-cell Malignancies
Sheba Medical Center
Phase 1/2 Recruiting
Clinical Trials
30 trialsNCT06409767 2025-09-24
ALHERT
University Hospital, Angers
Phase NA Recruiting
NCT06026046 2025-09-19
EscrimHEMA
University Hospital, Angers
Phase NA Active not recruiting
NCT06944119 2025-07-28
Assesment of the Immune Response to RSV Vaccine in Patients With Myeloma, Lymphoma and Hematological Leukemia
Tel-Aviv Sourasky Medical Center
Active not recruiting
NCT06795815 2025-06-12
OHGW-ACP
Azienda USL Reggio Emilia - IRCCS
Phase NA Recruiting
NCT06964841 2025-05-09
PRIMARY TESTICULAR LYMPHOMA
Instituto Mexicano del Seguro Social
Completed
NCT04263935 2025-04-23
Correlation Between Driver Gene Abnormalities and Clinicopathological Characteristics and Disease Prognosis in Lymphoma
Henan Cancer Hospital
Recruiting
NCT06307600 2025-01-23
The Safety and Efficacy of RD06-03 CART Cell Injection in Patients With R/R Acute B-lymphoblastic Leukemia
Anhui Provincial Hospital
Phase EARLY_PHASE1 Recruiting
NCT03346096 2024-07-09
TEAM
Sheba Medical Center
Phase 2 Completed
NCT05536154 2024-03-19
Etoposide+Cytarabine+PEG-rhG-CSF as First Line Mobilization Regimen of Hematopoietic Stem Cells in Patients With Hematological Malignancies
The Affiliated People's Hospital of Ningbo University
Phase NA Recruiting
NCT06262789 2024-02-16
RAT-HEMATO
University Hospital, Angers
Phase NA Not yet recruiting
NCT05982223 2023-08-08
Integrative Medicine in Lymphoma Survivors
Bnai Zion Medical Center
Phase NA Recruiting
NCT05528887 2022-09-06
Study of CAR-T Cell Therapy in the Treatment of Relapsed/Refractory Hematological Malignancies
The Affiliated People's Hospital of Ningbo University
Phase 1 Recruiting
NCT04746092 2021-08-16
The Capability of Haemato-oncology Patients to Generate Antibodies Against COVID-19
Tel-Aviv Sourasky Medical Center
Unknown
NCT04158414 2019-11-08
Applying PET/MR in Oncology - a Prospective Project
Tel-Aviv Sourasky Medical Center
Phase NA Unknown
NCT04154228 2019-11-06
Non-invasive Evaluation of Lymphoma Patients Based on Artificial Intelligence and PET/MRI
Tel-Aviv Sourasky Medical Center
Phase NA Unknown
NCT02389101 2019-08-05
MILY
Turku University Hospital
Phase NA Completed
NCT02526823 2019-04-02
Clinical Application of Polyethylene Glycol Liposome Doxorubicin (PLD) in Primary Lymphoma
Shandong Provincial Hospital
Phase 4 Unknown
NCT03765593 2018-12-05
pSS
National Council of Scientific and Technical Research, Argentina
Unknown
NCT03540303 2018-05-30
Cytoplasmic Activated PD-1 CAR T Cells in Refractory/Relapsed B Cell Lymphoma
Henan Cancer Hospital
Phase 1 Unknown
NCT02488382 2017-10-17
Lonquek for Autologous Stem Cell Mobilization
Sheba Medical Center
Phase 1/2 Unknown
NCT02265497 2017-08-18
Relinfo
Instituto Nacional de Cancer, Brazil
Unknown
NCT03062072 2017-04-07
ECHO
National Cancer Center, Korea
Unknown
NCT02072655 2016-06-16
CareSSE
University Hospital, Angers
Phase NA Completed
NCT00280878 2016-01-15
Rituximab in Combination With Outpatient Therapy for CD20+ Lymphoma
Bayside Health
Phase 2 Completed
NCT00163748 2016-01-08
Efficacy and Treatment Related Toxicity Study of a New Regimen for Lymphoma
Bayside Health
Phase 2 Completed
NCT00163761 2016-01-08
Efficacy Study of Outpatient Therapy for Lymphoma
Bayside Health
Phase 2 Completed
NCT01642563 2015-07-28
IPTAS
Centro Nazionale Sangue
Phase 3 Terminated
NCT00926757 2013-05-29
HBVNHL
Taipei Veterans General Hospital, Taiwan
Phase 4 Completed
NCT01300156 2011-02-21
Etoposide, Methylprednisolone, High-dose Cytarabine and Oxaliplatin (ESHAOx) for Refractory or Relapsed Hodgkin's Lymphoma (HL)
National Cancer Center, Korea
Phase 2 Unknown